Sign in →

Test ID LBOR0140 CYP2C19 Genotyping

Important Note

This testing requires that a Patient Acknowledgment Form for Pharmacogenomics Services must be filled out for all Medicare and non-Medicare patients and submitted with the sample for testing to be performed. In addition, Medicare patients require an ABN Form  to also be submitted with the specimen. In the absence of the appropriate signed form(s), the ordering provider/facility will be billed.

For patients with Blue Cross Blue Shield of North Dakota, a separate signed and completed Advance Member Notice is required to be submitted with the specimen.

Useful For

  • Identifying genetic changes known to have an effect on drug metabolism.
  • Interrogating the cause of personal or family history of an adverse drug reaction or therapeutic failure for a large group of drugs and thereby guide drug and dose selection.

Report Available

7 - 10 days

The report includes a comprehensive medication report based on the genotypes detected.